L'Oreal Completes Acquisition of Lactobio
By Andrea Figueras
L'Oreal has completed the acquisition of the Danish probiotic and microbiome research company Lactobio for an undisclosed amount.
The French beauty company said Monday that the move aims to boost its microbiome research efforts dedicated to beauty and strengthen its position in this particular scientific territory, the company said.
"The strategic acquisition builds on 20 years of advanced research by L'Oreal into the microbiome scientific territory," it said.
L'Oreal will be able to benefit from Lactobio's microbiome expertise and portfolio to develop topical formulations and new cosmetic solutions using live bacteria, the company said.
Write to Andrea Figueras at andrea.figueras@wsj.com
(END) Dow Jones Newswires
December 04, 2023 13:04 ET (18:04 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks